AfroCAB was formed in 2011 to facilitate community treatment access dialogue with multinational and generic drug manufacturing companies, policy makers, UN agencies, civil society organisations, and others working on anti HIV drugs and clinical research of new molecules and diagnostics.
AfroCAB was formed in 2011 to facilitate community treatment access dialogue with multinational and generic drug manufacturing companies, policy makers, UN agencies, civil society organisations, and others working on anti HIV drugs and clinical research of new molecules and diagnostics.